292 related articles for article (PubMed ID: 16579204)
1. An assessment of risk factors for the development of a second primary malignancy in the head and neck.
Bhattacharyya N
Ear Nose Throat J; 2006 Feb; 85(2):121-5. PubMed ID: 16579204
[TBL] [Abstract][Full Text] [Related]
2. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
3. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
7. [Second primary tumors in patients with carcinoma of the head and neck].
Herranz González-Botas J; Sarandeses García A; Martínez Vidal J; Vázquez Barro C; López Amado M
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):149-53. PubMed ID: 10804117
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Matsubara T; Yamada K; Nakagawa A
J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
11. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
12. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
[TBL] [Abstract][Full Text] [Related]
13. Second malignant neoplasia in early (TIS-T1) glottic carcinoma.
Sjögren EV; Snijder S; van Beekum J; Baatenburg de Jong RJ
Head Neck; 2006 Jun; 28(6):501-7. PubMed ID: 16673414
[TBL] [Abstract][Full Text] [Related]
14. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.
Bongers V; Braakhuis BJ; Tobi H; Lubsen H; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):595-8. PubMed ID: 8824360
[TBL] [Abstract][Full Text] [Related]
15. Primary cancer of the head and neck.
Reynolds W; Firkins R; Aguiar S
Iowa Med; 1993 Feb; 83(2):63-5. PubMed ID: 8432629
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx.
Lin K; Patel SG; Chu PY; Matsuo JM; Singh B; Wong RJ; Kraus DH; Shaha AR; Shah JP; Boyle JO
Head Neck; 2005 Dec; 27(12):1042-8. PubMed ID: 16265657
[TBL] [Abstract][Full Text] [Related]
17. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
Friedrich RE
Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
[TBL] [Abstract][Full Text] [Related]
18. Second head and neck cancers and tobacco usage.
Tomek MS; McGuirt WF
Am J Otolaryngol; 2003; 24(1):24-7. PubMed ID: 12579479
[TBL] [Abstract][Full Text] [Related]
19. [Second primary carcinomas in the upper aerodigestive tract in different locations and age groups].
Schwager K; Nebel A; Baier G; Hoppe F
Laryngorhinootologie; 2000 Oct; 79(10):599-603. PubMed ID: 11089209
[TBL] [Abstract][Full Text] [Related]
20. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx.
Chu PY; Chang SY; Huang JL; Tai SK
Am J Otolaryngol; 2010; 31(3):168-74. PubMed ID: 20015735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
